Edition:
United States

Fresenius Medical Care AG & Co KGaA (FMEG.DE)

FMEG.DE on Xetra

72.58EUR
1 Dec 2016
Change (% chg)

€-1.02 (-1.39%)
Prev Close
€73.60
Open
€73.29
Day's High
€73.34
Day's Low
€72.28
Volume
199,763
Avg. Vol
603,323
52-wk High
€85.65
52-wk Low
€70.00

Select another date:

Mon, Oct 31 2016

BRIEF-zfhn Zukunftsfonds Heilbronn sells XENIOS to Fresenius Medical Care

* Says has sold medical technology company XENIOS AG to Fresenius Medical Care AG & Co. KGaA

UPDATE 1-Fresenius group benefits from North America business, cost cuts

* Improvements driven by strong North America sales (Recasts throughout, adds details)

Fresenius SE notches up lower end of 2016 earnings guidance

FRANKFURT, Oct 27 German healthcare group Fresenius SE slightly upped its earnings guidance on Thursday, citing strong prospects for the remaining months of 2016 and a solid third-quarter performance.

BRIEF-Fresenius Medical Care confirms 2016 outlook

* Group revenue +9% (+9% at constant currency), driven by a strong performance in health care services

BRIEF-Germany's FMC buys Indian dialysis group Sandor Nephro

* Says acquires dialysis service provider Sandor Nephro services in India, which is expected to generate around $3 mln in 2016 revenues

UPDATE 2-Fresenius Medical's cost cuts lift earnings and shares

* Parent Fresenius raises FY profit goal on infusion drugs (Releads, adds shares, analyst comment)

Fresenius ups 2016 earnings goal after good first half

BERLIN German healthcare group Fresenius SE raised its profit target for the year after reporting a 12 percent rise in adjusted net income for the second quarter bolstered by the launch of new generic intravenous drugs and rivals' supply shortages.

BRIEF-FMC sticks to guidance after Q2 results

* Reuters poll average for fmc q2 net revenue was $4.44 billion, ebit $634 million, net income $284 million

Fresenius ups 2016 earnings guidance after good 1st half

BERLIN, Aug 1 German healthcare group Fresenius SE raised its profit target for the year on Monday after a better than expected performance in the first half of 2016.

Fitch Upgrades Fresenius to 'BBB-'; Outlook Stable

(The following statement was released by the rating agency) FRANKFURT/BARCELONA/LONDON, July 29 (Fitch) Fitch Ratings has upgraded Fresenius Medical Care AG & Co. KGaA's (FMC) and Fresenius SE & Co. KGaA's (FSE; together Fresenius) Long-Term Issuer Default Ratings to 'BBB-' from 'BB+'. The Outlooks are Stable. Fitch has also upgraded the Short-Term IDR to 'F3' from 'B'. A full list of rating actions is below. The upgrade reflects Fresenius' improving business risk profile, driven by its inc

Select another date: